Ensysce Biosciences, Inc. Announces Participation in LD Micro Main Event XV Conference

San Diego, California--(Newsfile Corp. - October 12, 2022) - Ensysce Biosciences, Inc. (NASDAQ: ENSC) (OTC Pink: ENSCW) ("Ensysce" or the "Company"), a clinical-stage biotech company applying transformative

Related Keywords

California ,United States ,San Diego ,Lynn Kirkpatrick ,Ensysce Biosciences ,Shannon Devine ,Dave Humphrey ,Hotel In Bel ,California Newsfile Corp ,Ensysce Biosciences Inc ,Mz Group North America ,Nasdaq ,Ensysce Biosciences Company Contact ,Luxe Sunset Boulevard Hotel ,Bel Air ,Chief Executive Officer ,Chief Financial Officer ,Investor Relations ,Trypsin Activated Abuse Protection ,Multi Pill Abuse Resistance ,Biosciences Investor Relations Contact ,Ensysce ,Iosciences ,Nnounces ,Participation ,Micro ,Rain ,Event ,Conference ,